Direkt zum Inhalt
Startseite

Dedicated to discovery

  • Über ELGA
    • Über ELGA
    • Karriere
    • Veranstaltungen
  • Service
    • Laborplanung
  • Kontakt
  • EN
  • ES
  • FR
  • IT
  • PT
  • EN-US
Startseite
  • Produkte
    • PURELAB
      • PURELAB® Dispenser
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • PURELAB® Chorus 2 +
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 150
      • MEDICA® 7/15
      • MEDICA® BIOX 2024
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY 30
    • Komplette Produktpalette
  • Anwendungen
    • Allgemeiner Laborwasserbedarf
    • Atomspektroskopie
    • Elektrochemie
    • Flüssigchromatographie
      • High Performance Liquid Chromatography
    • Gaschromatographie
    • Genetik
    • High Performance Liquid Chromatography (HPLC)
    • Immunchemie
    • Klinische Biochemie
    • Massenspektrometrie
    • Mikrobiologische Analyse
    • Spektrophotometrie
    • Zellkulturen
  • Technologien
    • Aktivkohle
    • Elektroentionisierung (EDI)
    • Filtration
    • Ionenaustausch
    • PureSure
    • Ultraviolettes Licht (UV)
    • Umkehrosmose (RO)
  • Verunreinigungen im Wasser
    • Anorganische Verbindungen
    • Gelöste Gase
    • Mikroorganismen und Bakterien
    • Organische Verbindungen
    • Partikel
  • Wissen
    • BROSCHÜREN
    • Blog
    • Referenzen
    • Reinstwasser
    • Whitepaper rund um Laborwasser
  • Where to buy
  • Kontakt
Home
  • Kontakt
  • Produkte
    • PURELAB
      • PURELAB® Dispenser
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • PURELAB® Chorus 2 +
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 150
      • MEDICA® 7/15
      • MEDICA® BIOX 2024
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY 30
    • Komplette Produktpalette
  • Anwendungen
    • Allgemeiner Laborwasserbedarf
    • Atomspektroskopie
    • Elektrochemie
    • Flüssigchromatographie
      • High Performance Liquid Chromatography
    • Gaschromatographie
    • Genetik
    • High Performance Liquid Chromatography (HPLC)
    • Immunchemie
    • Klinische Biochemie
    • Massenspektrometrie
    • Mikrobiologische Analyse
    • Spektrophotometrie
    • Zellkulturen
  • Technologien
    • Aktivkohle
    • Elektroentionisierung (EDI)
    • Filtration
    • Ionenaustausch
    • PureSure
    • Ultraviolettes Licht (UV)
    • Umkehrosmose (RO)
  • Verunreinigungen im Wasser
    • Anorganische Verbindungen
    • Gelöste Gase
    • Mikroorganismen und Bakterien
    • Organische Verbindungen
    • Partikel
  • Wissen
    • BROSCHÜREN
    • Blog
    • Referenzen
    • Reinstwasser
    • Whitepaper rund um Laborwasser
  • Where to buy
  • Kontakt
  • Über ELGA
    • Über ELGA
    • Karriere
    • Veranstaltungen
  • Service
    • Laborplanung
  • Kontakt
  • EN
  • ES
  • FR
  • IT
  • PT
  • EN-US
  • Datenschutzerklärung
  • Geschäftsbedingungen
  • Globale Entsprechenserklärungen
  • Patente
  • Trademarks
  • Impressum
  • ELGA PURELAB Helps Standardize Antibiotic Susceptibility Testing
Clinical & Pharma
Science of the Future

ELGA PURELAB Helps Standardize Antibiotic Susceptibility Testing

29 Feb. 2020
- by Dr Alison Halliday

Female scientist analyzing growing bacterial cultures in petri dish in laboratory, science and microbiology background

Using Ultrapure Water in Antibiotic Susceptibility Testing

A new study makes recommendations for combining two different methods to test bacterial susceptibility to antibiotics, which could help improve reproducibility between laboratories and provide more clinically relevant information for treating infections.

Every day, thousands of experimental and diagnostic laboratories around the world are carrying out antimicrobial susceptibility testing (AST) to search for an effective antibiotic to use against a bacterial strain. But results can vary widely between laboratories, and there is a need to create standardized protocols to improve reproducibility and reliability of results.

One of the main techniques used by laboratories is measuring the minimum inhibitory concentration (MIC). This gauges the lowest antibiotic concentration that inhibits the visible growth of a microorganism after incubation for 16-20 hours.  But this test has limitations - it doesn’t reveal whether the drug kills the bacteria, or just halts its growth. And crucially, it’s not good at predicting the antibiotic’s actual effectiveness within the body.

A Killer Concentration

Another measure is to define an antibiotic’s minimal bactericidal concentration (MBC), which defines the lowest concentration that’s needed to kill the bacteria. This is especially important for patients with inflammatory diseases or who are immunocompromised - as their immune system may not be working well enough to fully eliminate the pathogens should an antibiotic only inhibit its growth.

Determining the MBC involves a test to work out the lowest concentration of an antibiotic that reduces the number of bacterial colonies on subculture by 99.9%. But this test attracts criticism, due to its poor reproducibility between laboratories. Involving broth dilution and re-growth of bacteria in antibiotic-free media, potential variables include the size of the inoculum, sample mixing and growth phase of the bacteria.

Combining MBC and MIC Approaches

Assessing both the MBC and MIC may be a more useful strategy for determining the clinical relevance of an antibiotic. A new study, published in the Journal of Microbiological Methods, carried out an objective, detailed comparison of a range of different methodologies for determining the MIC and MBC (1). 

The researchers tested two bacterial strains, P.aeruginosa PA01 and E.coli ATCC 25922 against four antibiotics: gentamicin, tobramycin, ciprofloxacin, and colistin – as well as S.aureus, which they additionally tested with vancomycin. They used ultrapure water purified using PURELAB Flex apparatus from ELGA LabWater for the preparation and analysis of all samples.

The team worked out the MIC using broth microdilution, a calorimetric method and a microscopy-based screening system (MBSS). For determining the MBC, they carried out flurophore staining, comparing this with the broth regrowth method.

New Recommendations to Assess Antibiotics

After evaluating their results, the researchers recommend different combinations of methods to determine the MIC and MBC, depending on whether time, cost or sensitivity is the main priority. They also emphasize the importance of uniform protocols across different laboratories, including a suggested standardization of the timepoint for reading MIC results of 20 hours.

This important new study proposes new recommendations for the best methods to assess which antibiotics are effective against a bacterial strain. These will help improve reproducibility across laboratories, gain more clinically relevant data, and enable a better understanding of the action of antibiotic drugs.

Why Choose ELGA LabWater?

We are the LabWater Specialists since 1937 we have been working with scientists to guarantee pure and ultrapure water for their experiments and lab work. Laboratories around the world trust our laboratory water purification systems to help their researchers to achieve accurate, reliable results.


References

(1)  Klodzinska et al. Combining diagnostic methods for antimicrobial susceptibility testing – a comparative approach. Journal of Microbiological Methods 144 (2018), p177-185.
 

Dr Alison Halliday
After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

  • Sales Enquiry
  • Angebot anfordern
  • Technical Support
  • Einen Ansprechpartner finden

Sales Enquiry

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

Ich habe die Datenschutzerklärung gelesen und verstanden

Angebot anfordern

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

Ich habe die Datenschutzerklärung gelesen und verstanden

Technical Support

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater Deutschland

ELGA LabWater
Veolia Water Technologies Deutschland GmbH
Speicherstraße 14 A
29221 Celle
T: +49 (0) 51 41 803 0
F: +49 (0) 51 41 803 384

Referenzen

  • Abbott Diagnostics
  • DASA Medical Diagnostics
  • NeoDIN Medical Institute
  • North Staffordshire NHS Trust
  • Berufskolleg Olsberg

Ressourcen

  • Erfahren Sie mehr über Reinstwasser
  • Whitepaper rund um Laborwasser
  • Technologien zur Wasseraufbereitung
  • Laboranwendungen
  • Verunreinigungen im Wasser
  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?

© VWS (UK) Ltd, handelnd als ELGA LabWater.2025- Alle Rechte vorbehalten.
ELGA ist der globale Markenname von Veolia für Laborwasser.

  • Datenschutzerklärung
  • Geschäftsbedingungen
  • Globale Entsprechenserklärungen
  • Patente
  • Trademarks
  • Impressum
  • Sprache
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Andere Veolia Webseiten
    • Veolia
    • Veolia Foundation
    • Veolia Water Technologies
Elga Veolia
TOP

© 2017 ELGA Veolia